Document is current
Any future updates will be listed below
-
Authors
Hoang, Karen https://orcid.org/0000-0002-2846-6852
Watt, Hilary
Golemme, Mara
Perry, Richard J.
Ritchie, Craig
Wilson, Danielle
Pickett, James
Fox, Chris
Howard, Robert
Malhotra, Paresh A.
-
Funding
Funding for this research was provided by:
Research for Patient Benefit Programme (PB-PG-0214-33098)
Takeda Pharmaceuticals U.S.A. (PB-PG-0214-33098)
- License Information
-
More Information
Article History
Received: 12 January 2022
Accepted: 20 March 2022
First Online: 1 August 2022
Declarations
:
: The London-Westminster Research Ethics Committee (REC) - Health Research Authority (HRA) granted favourable ethical opinion on 12 September 2016 (REC reference: 16/LO/1258). The Medicines and Healthcare Products Regulatory Agency (MHRA) accepted the Clinical Trial Authorisation application on 03 March 2017 (MHRA reference: 19174/0377/001/0001).Trained members of the research team introduce the trial to patients and their study partners. An information sheet is offered, and time is given for consideration. Participants are able to have an informed discussion with the research team. Written consent is obtained from patients and study partners who are willing to participate in the trial.
: The authors declare that they have no competing interests.
